Cláudia Camila Dias1, Mafalda Santiago2, Luís Correia3, Francisco Portela4, Paula Ministro5, Paula Lago6, Eunice Trindade7, Alberto Freitas1, Fernando Magro8. 1. Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine of the University of Porto, Portugal; CINTESIS - Center for Health Technology and Services Research, Porto, Portugal. 2. CINTESIS - Center for Health Technology and Services Research, Porto, Portugal; IBD Portuguese Group (GEDII), Porto, Portugal. 3. IBD Portuguese Group (GEDII), Porto, Portugal; Santa Maria Hospital, Gastroenterology Department, Lisbon, Portugal. 4. IBD Portuguese Group (GEDII), Porto, Portugal; Coimbra Hospital, Gastroenterology Department, Coimbra, Portugal. 5. IBD Portuguese Group (GEDII), Porto, Portugal; Viseu Tondela Hospital, Gastroenterology Department, Viseu, Portugal. 6. IBD Portuguese Group (GEDII), Porto, Portugal; Santo António Hospital, Gastroenterology Department, Porto, Portugal. 7. IBD Portuguese Group (GEDII), Porto, Portugal; São João Hospital, Gastroenterology Department, Porto, Portugal. 8. IBD Portuguese Group (GEDII), Porto, Portugal; São João Hospital, Gastroenterology Department, Porto, Portugal; Unit of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Portugal; MedInUP - Center for Drug Discovery and Innovative Medicines, University of Porto, Porto, Portugal. Electronic address: fm@med.up.pt.
Abstract
INTRODUCTION: In this study, we aimed to determine the hospitalization rates of Inflammatory Bowel Disease (IBD) in a southern-european country and its associated charges over a period of 16 years. METHODS: We identified all discharges with a primary diagnosis of Crohn's disease (CD) or ulcerative colitis (UC) between 2000 and 2015 in data provided by the Central Administration of Health Services (ACSS). National estimates of hospitalization rates were assessed and adjusted to gender, age, population, and hospitalizations. Hospitalization charges were also assessed. RESULTS: There were an estimated 31 358 and 16 669 discharges for CD and UC, respectively. From 2000 to 2015, hospitalization rates per 100000 habitants increased for CD (8.4-11.2) and remained stable for UC (4.4-4.9). The hospitalization rate for IBD increased slightly over time (12.8 per 100 000 habitants in 2000 and 16.1 in 2015). Annual total hospitalization charges amounted to 4.0M€ in 2000 and 5.7M€ in 2015. This increase was mainly due to a rise in the total expenses of CD-related hospitalizations. CONCLUSION: CD hospitalization rates per 100000 inhabitants increased over time while remaining constant for UC. Hospitalization charges for IBD increased approximately 2.0M€ during the study period, representing an important burden in the national healthcare system.
INTRODUCTION: In this study, we aimed to determine the hospitalization rates of Inflammatory Bowel Disease (IBD) in a southern-european country and its associated charges over a period of 16 years. METHODS: We identified all discharges with a primary diagnosis of Crohn's disease (CD) or ulcerative colitis (UC) between 2000 and 2015 in data provided by the Central Administration of Health Services (ACSS). National estimates of hospitalization rates were assessed and adjusted to gender, age, population, and hospitalizations. Hospitalization charges were also assessed. RESULTS: There were an estimated 31 358 and 16 669 discharges for CD and UC, respectively. From 2000 to 2015, hospitalization rates per 100000 habitants increased for CD (8.4-11.2) and remained stable for UC (4.4-4.9). The hospitalization rate for IBD increased slightly over time (12.8 per 100 000 habitants in 2000 and 16.1 in 2015). Annual total hospitalization charges amounted to 4.0M€ in 2000 and 5.7M€ in 2015. This increase was mainly due to a rise in the total expenses of CD-related hospitalizations. CONCLUSION:CD hospitalization rates per 100000 inhabitants increased over time while remaining constant for UC. Hospitalization charges for IBD increased approximately 2.0M€ during the study period, representing an important burden in the national healthcare system.
Authors: Joana Roseira; Helena T Sousa; Ana Marreiros; Luís F Contente; Fernando Magro Journal: Health Qual Life Outcomes Date: 2021-02-18 Impact factor: 3.186